Outlier BioPharma Inc. — Form D/A
Outlier BioPharma Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2018-08-07. The offering totals $5.0M, of which $50K was reported sold. Industry: Other.
Offering
- Filed: 2018-08-07
- Form: D/A
- Accession: 0001553350-18-000911
- Industry: Other
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $50K
- Remaining: $5.0M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2018-06-11
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-315075
Issuer
- Name: Outlier BioPharma Inc.
- CIK: 0001690961
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 955 MASSACHUSETTS AVE., CAMBRIDGE, MA, 02139
- Phone: (617) 899-5636
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Javid Nickpour | Director | Andover, MA |
| Emelio Williams | Director | Cambridge, MA |
| Emelio Williams | Executive Officer | Cambridge, MA |
Other filings by this issuer (2)
More